Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 53 | 48 | 43 | 35 | -33 |
| Accounts receivable | 195 | 186 | 105 | -543 | 77 |
| Other Working Capital | 520 | 359 | -632 | -937 | 497 |
| Other Operating Activity | -1,202 | -821 | -203 | -150 | -1,104 |
| Operating Cash Flow | $-435 | $-228 | $-687 | $-1,595 | $-563 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | -1 | -2 | 0 |
| Purchase Sale Intangibles | -284 | -38 | 0 | -228 | -97 |
| Investing Cash Flow | $-286 | $-40 | $-1 | $-229 | $-97 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -70 | 0 | -21 | 3,832 | N/A |
| Other Financing Activity | -33 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-104 | $0 | $-21 | $3,832 | $0 |
| Beginning Cash Position | 3,686 | 3,953 | 4,717 | 2,492 | 3,062 |
| End Cash Position | 2,794 | 3,686 | 4,008 | 4,499 | 2,430 |
| Net Cash Flow | $-824 | $-268 | $-709 | $2,007 | $-660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -435 | -228 | -687 | -1,595 | -563 |
| Capital Expenditure | -286 | -40 | -1 | -229 | -97 |
| Free Cash Flow | -720 | -268 | -688 | -1,825 | -661 |